moa glp 1 agonist Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Emerging Frontiers in GLP-1 Therapeutics:
Description
SCFAs activate free fatty acid receptors FFAR2 and FFAR3 on L-cells, thereby stimulating GLP-1 secretion
doi:10.1136/bmj-2024-080679 Written by Dr
T., Sjoholm, A
doi: 10.1016/j.cmet.2018.03.001 [DOI] [PubMed] [Google Scholar] 2.Holt MK, Richards JE, Cook DR, et al
doi: 10.1007/s11255-020-02585-w 35 BernardiSMichelliAZuoloGCandidoRFabrisB
